Antibody was affinity purified using an epitope specific to LAP2 alpha beta gamma/TMPO immobilized on solid support. The epitope recognized by A304-838A maps to a region between residue 1 to 50 of human LAP2 alpha beta gamma/TMPO using the numbering given in entry P42166 (GeneID 7112). Antibody concentration was determined by extinction coefficient: absorbance at 280 nm of 1.4 equals 1.0 mg of IgG.
CMD1T, lamina-associated polypeptide 2, LAP2, LEM domain containing 4, LEMD4, PRO0868, thymopoietin, thymopoietin beta, Thymopoietin isoform alpha, Thymopoietin, isoforms beta/gamma, thymopoietin-related peptide isoform alpha, thymopoietin-related peptide
Between 1 and 50
2 - 8°C
Detection of human LAP2 alpha and LAP2 beta by western blot. Samples: Whole cell lysate (50 µg) from HeLa, HEK293T, and Jurkat cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-LAP2 alpha beta gamma antibody A304-838A (lot A304-838A-1) used for WB at 0.1 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.
Detection of human LAP2 alpha and beta by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LAP2 alpha beta gamma antibody A304-838A (lot A304-838A-1) used for IP at 6 µg per reaction. LAP2 alpha was also immunoprecipitated by rabbit anti-LAP2 alpha antibody A304-839A. LAP2 beta was immunoprecipitated by rabbit anti-LAP2 beta antibodies A304-840A and A304-841A, and by rabbit anti-LAP2 beta gamma antibodies A304-849A and A304-850A. For blotting immunoprecipitated LAP2 alpha and beta, A304-838A was used at 1 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.